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~ Cardiac Risk Assessment Following Vascular 
Surgery-- Independent Validation of a Bayesian 
Prediction Model 
Gilbert J. Ultalien, Sumita D. Paul, Robert C. Hendal, Mylan C. Cohen, Lee 
A. Reisher, Kenneth A. Brown, Stuart W, Zarich, Jeffrey A. LSPpo, Kim 
A. Eagle. Massachusetts Hospital Boston, MA, Univ. of Massachusetts, 
Worcester, MA; Deaconess Hospital, Boston, MA; Univ. of Vermont, 
Burlington VT~; Johns Hopkins Univ., Baltimore, MD; Yale Univ., New Haven 
Ct. Northwestern Univ, Chicago, ILL; Unfv. of Michigan, Ann Arbor, MI 
We previously described a Bayesian cardiac risk prediction model developed 
from a "training" set of 567 vascular surgery pts from 2 medical centers (43rd 
ACC). Here, we report he results of a validation based on 514 additional pts 
from 3 centers. The original model permitted sequential estimation of dsk of 
fatal/non-fatal MI based on surgery type (TYPE), TYPE + clinical markers 
(CLIN): (HxMI, Angina, CHF, Diabetes, age > 70 y, pdor CABG), and TYPE 
+ CLIN + dlpyridamole thallium data (fixed/reversible defects, ischemic ST 
changes). Model performance was assessed using receiver operator curves 
(ROC) and by comparing observed event rates to risk estimates. 
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Results are shown above for both the training and validation sets (1,081 
patients). Figure I: ROC areas were 81 -I- 3% for the training set and 74 
± 9%, 72:1: 7%, and 76 -~ 5% for each of the 3 validation setS (p = NS). 
Figure 2: Observed and estimated sks were comparable for the training 
set ("goodness of fit" p = 0.75), and all 3 validation sets (p = 0.55, 0.10, 
0.45, respectively). Conclusions:The Bayesian prediction model can reliably 
estimate the risk of a pedoperative cardiac event in beth the training and 
validation setS and is thus generalizable to the vascular surgery population. 
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["~"0--~ Evaluation of Selntigraphy Ventilction/Perfusion 
Using Tc-99m Diethylenetriamine Pantaceti¢ Acid 
(OTIPA) Aerosol in the Diagnosis of Pulmonary 
Embol ism 
Nelson P. Trujillo, Jonathan P. Pratt, Sachin Talusani, Robert A. Qualfo, 
O~vid Kumpe, James L. Lear. University of Colorado Health Sciences 
Center, Denver. CO 
Ventilation/pedusion (V/Q) scintigraphy has generally been performed using 
Xenon-133 for ventilation. However, PIOPED and other studies that have em- 
ployed this technique have raised questions about accuracy in the diagnosis 
of pulmonary embolism (PC-). 
We evaluated the accuracy of V/Q scintigraphy using Tc-ggm DTPA 
aerosol, as opposed to Xenon-133, in the evaluation of suspected PE. The 
use of Tc-99m DTPA oilers potential advantages: greater esolution and the 
ability to perform ventilefidn imaging in the same eight views as those of the 
perfusion study. 
Diagnostic riteria developed specifically for Tc-99m DTPA aerosol were 
prospectively applied to 2922 patients being evaluated for suspected PE 
over a six year period. Of these patients, 16% had normal V/Q scans, 
56% had low probability scans, 10% had indeterminate scans, 9% had 
medium probability scans, and 9°/= had high probability scans. The total 
percent of scans in normal, high, or low categories was 81%, compared to 
61% in PIOPED. Pulmonary angiography was performed on 264 patients. 
Pulmonary emholic disease was identified in 0/1 ((T/O) of normal scans, 3/59 
(5%) of low probability scans, 13/54 (24%) of Indeterminate scans, 35/94 
(43%) of medium probability scans, and 53/56 (95%) of high probability 
scans. Estimated incidence of PE in the total population was 15%. 
These results indicate that V/Q scintigraphy using Tc-99m DTPA aerosol 1) 
is useful in the diagnosis of pulmonary emholic disease and 2) has accuracy 
which is superior to published results using Xenon-133, including PIOPED. 
We believe that Tc-99m DTPA aerosol should replace Xenon-133 in V/L~ 
scintigraphy for the diagnosis of suspected pulmonary embolism, 
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~0"~ AnticoagulaUon Monitoring: Accurate Results W'dh 
Patient Self-Tssting in a Multieentar Trial 
Richard Becker, Daniel Becker, Maureen Andrew, Jack Ansell, 
Douglas Tdplett, Catherine Cimini, Frank LaDuca, and the Oral 
Anticoagulation Study Investigators. Thrombosis Research Center, 
University of Massachusetts Medical Center, Worcester, MA 
A novel whole blood Prothrombin "rime (PT) system (ProTIME Micrecoagu. 
lation System, International Technidyne Co., Edison, NJ), was tested in five 
anticoagulation clinics to assess the patient's ~,b!tity to collect and test a 
finger.stick blond sample (FS) and to assess the accuracy of the ProTIME 
result (INR) with the lab plasma assay. FS and venous samples (VS) were 
obtained from control volunteers (n = 65) and patients receiving warfarin 
(n = 230). Written, video, and verbal instruction was provided by a Health 
Care Professional (HCP). Once collected, blood was automatically tested in 
triplicate with concurrent control tests. VS was sent to the hospital lab for 
testing (ISI ranging 1.2 to 2.1). A sample of the plasma was shipped to a 
reference lab where the assay was repeated (Recemboplastin, ISI = 1.0). 
The HCP noted patient attempts necessary to obtain a ProTIME result. The 
first attempt was successful for 83% of the patients. An additional 10% were 
successful in the second trY. Most graded the monitor "Easy" to use (65%) 
while few identified it"Difficult" (7.5%). Participants preferred the FS sampling 
method (92%). No difference was detected between ProTIME results of VS 
and FS (Student's t Test). The ProTIME INR was significantly correlated to 
the reference lab (r = 0.94 for VS and r = 0.93 for FS). The correlation of FS 
to each hospital site ranged from r = 0.89 to r = 0.93. Conclusion: Patients 
prefer and can readily test themselves with the ProTIME Monitor yielding test 
results that are highly correlated to the laboretory. 
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J ' ~  The Effect of Public Release of Bypass Surgery  
Mortality Data on Procedural Access in the Elderly: 
New York State 
Eric D. Peterson, James G. Jollis, Elizabeth R. DeLong, S. Robert Collins, 
Lawrence H. Muhlbaler, Daniel B. Mark. Duke University Medical Center, 
Durham, NC 
New York (NY) State has released provider-level bypass surgery (CABG) 
mortal~ data since 1989. Some spaculate that this policy may force higher- 
dsk patients, particularly the elderly, to go out.of-state for CABG or to forgo 
intervention. Using Medicare data, we examined CABG use in and outside 
NY. We tested (1) whether the % of patients aged _> 65 years who received 
CABG outside NY increased from 1987 to 1992 and (2) whether CABG use 
declined in NY in higher-risk patients, defined as those aged >_ 70 years with 
acute MI (AMI), versus US practice patterns dudng this pedod. 
1967 1988 1989 1990 1991 1992 
NY Medicare CABG 
re~pients, n 5488 5784 6148 7093 8279 9075 
Out-of-State CABG, % 13.2 15.0 14.8 13.1 13.3 11.6 
NY PIs aged_> 70 yr 
with AMI + CABG, % 4.4 5.8 6.3 8.8 7.7 8.1 
US Pts age > 70 yr with 
AMI + CABG, % 6.9 8.4 9.2 10.5 10A 11.1 
The % of NY's elderly migrating out-of-state for CABG has declined since 
the release of provider profiling data. In addition, an increasing % of NY's 
high-risk elderly patients with AMI received CABG over this period in parallel 
with national practice panems. 
Conclusion: Public release of provider-level CABG mortality data in NY 
does not appear to have limited access to CABG procedures for the eldedy. 
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[~]  Potentiel for Cost in Cost Coronary Savings High 
Bypass Surgery Patients: A New York State Analysis 
Patdcia A. Cowper, Elizabeth R. DeLong, Edc 3. Feterson, Edward 
L. Hannan, Kevin T. Ray, Michael Racz, James G. Joitis. Daniel B. Mark, 
Duke University Medical Center, Durham, NC 
To assess potential for cost savings, we examined the extent and sources 
